<?xml version="1.0" encoding="UTF-8"?>
<ref id="B319-vaccines-08-00036">
 <label>319.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Van der Velden</surname>
    <given-names>Y.U.</given-names>
   </name>
   <name>
    <surname>Kleibeuker</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Harwig</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Klaver</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Siteur-van Rijnstra</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Frankin</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Berkhout</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Das</surname>
    <given-names>A.T.</given-names>
   </name>
  </person-group>
  <article-title>Construction of Nef-positive doxycycline-dependent HIV-1 variants using bicistronic expression elements</article-title>
  <source>Virology</source>
  <year>2016</year>
  <volume>488</volume>
  <fpage>96</fpage>
  <lpage>107</lpage>
  <pub-id pub-id-type="doi">10.1016/j.virol.2015.11.004</pub-id>
  <?supplied-pmid 26615334?>
  <pub-id pub-id-type="pmid">26615334</pub-id>
 </element-citation>
</ref>
